Adaptation and Validation of the Arabic Version of EuroQol 5D-5L
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03504384|
Recruitment Status : Not yet recruiting
First Posted : April 20, 2018
Last Update Posted : April 20, 2018
The aim of the work is to provide a validated Arabic version of EuroQol 5D-5L ,so that it would be used as a quality of life assessment tool for Egyptian patients
- Cross cultural adaptation of the translated Arabic version of EuroQol 5D-5L.
- Assessment of the reliability of the translated Arabic version of EuroQol 5D-5L.
- Testing the validity of the translated version of EuroQol 5D-5L.
|Condition or disease||Intervention/treatment|
|Validation Study||Other: questionnaire|
|Study Type :||Observational|
|Estimated Enrollment :||160 participants|
|Official Title:||Cross Cultural Adaptation and Validation of The Arabic Version Of EuroQol 5D-5L|
|Estimated Study Start Date :||May 1, 2018|
|Estimated Primary Completion Date :||May 1, 2019|
|Estimated Study Completion Date :||June 1, 2019|
- Other: questionnaire
All patients will be interviewed using a semi-structured questionnaire detailing patients' demographic characteristics (age, sex, education, occupation, residence), and the factors that could affect their quality of life such as pain and neurological symptoms, orthopedic disorder in another part of the body and history of spinal surgery.
- A reliable and validated Arabic version of the EQ-5D-5L instrument [ Time Frame: basline ]Cross cultural adaptation and validation of the Arabic version of the EQ-5D-5L.
- factors affecting quality of life of spine disease patients. [ Time Frame: baseline ]to study factors affecting quality of life of spine disease patients.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03504384
|Contact: Ahmed Mahmoud Ahmedemail@example.com|
|Contact: Ahmed Shawky Abdelgawaad, Drfirstname.lastname@example.org|